Evidence map›Paper›PMID 36742333›Full record

ArticleFrontiers in immunology2023

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures.

Tao Wang, Tianye Li, Baiqing Li, Jiahui Zhao, Zhi Li, Mingyi Sun, Yan Li, Yanjiao Zhao, Shidi Zhao, Weiguang He and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Tao WangCollege of Life and Health Sciences, Northeastern University, Shenyang, China.
Tianye LiCollege of Life and Health Sciences, Northeastern University, Shenyang, China.
Baiqing LiDepartment of Immunology, Bengbu Medical College, Bengbu, China.
Jiahui ZhaoCollege of Life and Health Sciences, Northeastern University, Shenyang, China.
Zhi LiCollege of Life and Health Sciences, Northeastern University, Shenyang, China.
Mingyi SunCollege of Life and Health Sciences, Northeastern University, Shenyang, China.
Yan LiDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Yanjiao ZhaoCollege of Life and Health Sciences, Northeastern University, Shenyang, China.
Shidi ZhaoDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Weiguang HeDepartment of Radiology, Tian Jin Fifth's Central Hospital, Tianjin, China.
Xiao GuoCollege of Pharmacy, Beihua University, Jilin, China.
Rongjing GeDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Lian WangDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Dushan DingDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Saisai LiuDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Simin MinDepartment of Pathophysiology, Bengbu Medical College, Bengbu, China.
Xiaonan ZhangCollege of Life and Health Sciences, Northeastern University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.805184.].

Indexed as

breast cancerimmune escapeimmune subtypeimmunotherapytumor microenvironment

Identifiers

PMID36742333
PMCPMC9896161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.